Literature DB >> 30048707

20-HETE in the regulation of vascular and cardiac function.

Petra Rocic1, Michal Laniado Schwartzman2.   

Abstract

20-HETE, the ω-hydroxylation product of arachidonic acid catalyzed by enzymes of the cytochrome P450 (CYP) 4A and 4F gene families, is a bioactive lipid mediator with potent effects on the vasculature including stimulation of smooth muscle cell contractility, migration and proliferation as well as activation of endothelial cell dysfunction and inflammation. Clinical studies have shown elevated levels of plasma and urinary 20-HETE in human diseases and conditions such as hypertension, obesity and metabolic syndrome, myocardial infarction, stroke, and chronic kidney diseases. Studies of polymorphic associations also suggest an important role for 20-HETE in hypertension, stroke and myocardial infarction. Animal models of increased 20-HETE production are hypertensive and are more susceptible to cardiovascular injury. The current review summarizes recent findings that focus on the role of 20-HETE in the regulation of vascular and cardiac function and its contribution to the pathology of vascular and cardiac diseases.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  20-HETE; Angiogenesis; Cytochrome P450; Heart failure; Hypertension; Myocardial infarction; Vascular remodeling

Mesh:

Substances:

Year:  2018        PMID: 30048707      PMCID: PMC6278600          DOI: 10.1016/j.pharmthera.2018.07.004

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  227 in total

1.  Cytochrome P450-dependent arachidonic acid metabolism in human kidney.

Authors:  M L Schwartzman; P Martasek; A R Rios; R D Levere; K Solangi; A I Goodman; N G Abraham
Journal:  Kidney Int       Date:  1990-01       Impact factor: 10.612

Review 2.  Epigenetic Regulation of Cytochrome P450 Enzymes and Clinical Implication.

Authors:  Xiaojing Tang; Shuqing Chen
Journal:  Curr Drug Metab       Date:  2015       Impact factor: 3.731

3.  Disturbed ratio of renal 20-HETE/EETs is involved in androgen-induced hypertension in cytochrome P450 4F2 transgenic mice.

Authors:  Xiaoliang Liu; Jingjing Wu; Hong Liu; Guangrui Lai; Yanyan Zhao
Journal:  Gene       Date:  2012-02-24       Impact factor: 3.688

4.  Haplotype-based case-control study of CYP4A11 gene and myocardial infarction.

Authors:  Zhenyan Fu; Tomohiro Nakayama; Naoyuki Sato; Yoichi Izumi; Yuji Kasamaki; Atsushi Shindo; Masakatsu Ohta; Masayoshi Soma; Noriko Aoi; Mikano Sato; Yukio Ozawa; Yitong Ma
Journal:  Hereditas       Date:  2012-07-04       Impact factor: 3.271

5.  Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats.

Authors:  Kimberly M Hoagland; Kristopher G Maier; Richard J Roman
Journal:  Hypertension       Date:  2002-12-09       Impact factor: 10.190

6.  Elevated renovascular tone in young spontaneously hypertensive rats. Role of cytochrome P-450.

Authors:  J D Imig; J R Falck; D Gebremedhin; D R Harder; R J Roman
Journal:  Hypertension       Date:  1993-09       Impact factor: 10.190

7.  Human heme oxygenase-1 gene transfer lowers blood pressure and promotes growth in spontaneously hypertensive rats.

Authors:  H E Sabaawy; F Zhang; X Nguyen; A ElHosseiny; A Nasjletti; M Schwartzman; P Dennery; A Kappas; N G Abraham
Journal:  Hypertension       Date:  2001-08       Impact factor: 10.190

8.  Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase.

Authors:  Cheng-Chia Wu; Jennifer Cheng; Frank Fan Zhang; Katherine H Gotlinger; Mukul Kelkar; Yilun Zhang; Jawahar L Jat; John R Falck; Michal L Schwartzman
Journal:  Hypertension       Date:  2011-02-14       Impact factor: 10.190

9.  Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.

Authors:  Cheng-Chia Wu; Shaojun Mei; Jennifer Cheng; Yan Ding; Adam Weidenhammer; Victor Garcia; Fan Zhang; Katherine Gotlinger; Vijaya L Manthati; John R Falck; Jorge H Capdevila; Michal L Schwartzman
Journal:  J Am Soc Nephrol       Date:  2013-05-02       Impact factor: 10.121

10.  Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension.

Authors:  Harpreet Singh; Jennifer Cheng; Huan Deng; Rowena Kemp; Tsuneo Ishizuka; Alberto Nasjletti; Michal Laniado Schwartzman
Journal:  Hypertension       Date:  2007-06-04       Impact factor: 10.190

View more
  20 in total

1.  Proximal tubular-targeted overexpression of the Cyp4a12-20-HETE synthase promotes salt-sensitive hypertension in male mice.

Authors:  Ankit Gilani; Kevin Agostinucci; Jonathan V Pascale; Sakib Hossain; Sharath Kandhi; Varunkumar Pandey; Victor Garcia; Alberto Nasjletti; Michal Laniado Schwartzman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-06-17       Impact factor: 3.619

Review 2.  Comparison of Cardiovascular Benefits of Bariatric Surgery and Abdominal Lipectomy.

Authors:  Petra Rocic
Journal:  Curr Hypertens Rep       Date:  2019-04-05       Impact factor: 5.369

3.  CYP4A/20-HETE regulates ischemia-induced neovascularization via its actions on endothelial progenitor and preexisting endothelial cells.

Authors:  Li Chen; Samantha Tang; Frank F Zhang; Victor Garcia; John R Falck; Michal L Schwartzman; Ali S Arbab; Austin M Guo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-04-05       Impact factor: 4.733

4.  Blockade of 20-hydroxyeicosatetraenoic acid receptor lowers blood pressure and alters vascular function in mice with smooth muscle-specific overexpression of CYP4A12-20-HETE synthase.

Authors:  Kevin Agostinucci; Rebecca Hutcheson; Sakib Hossain; Jonathan V Pascale; Elizabeth Villegas; Frank Zhang; Adeniyi Michael Adebesin; John R Falck; Sachin Gupte; Victor Garcia; Michal Laniado Schwartzman
Journal:  J Hypertens       Date:  2022-03-01       Impact factor: 4.844

Review 5.  Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Authors:  John A McClung; Lior Levy; Victor Garcia; David E Stec; Stephen J Peterson; Nader G Abraham
Journal:  Pharmacol Ther       Date:  2021-09-06       Impact factor: 12.310

6.  Neutrophil-Derived Myeloperoxidase and Hypochlorous Acid Critically Contribute to 20-Hydroxyeicosatetraenoic Acid Increases that Drive Postischemic Angiogenesis.

Authors:  Juan A Azcona; Samantha Tang; Elizabeth Berry; Frank F Zhang; Radha Garvey; John R Falck; Michal Laniado Schwartzman; Tao Yi; Thomas M Jeitner; Austin M Guo
Journal:  J Pharmacol Exp Ther       Date:  2022-03-19       Impact factor: 4.402

Review 7.  Unraveling the Role of 12- and 20- HETE in Cardiac Pathophysiology: G-Protein-Coupled Receptors, Pharmacological Inhibitors, and Transgenic Approaches.

Authors:  Jonathan V Pascale; Pamela A Lucchesi; Victor Garcia
Journal:  J Cardiovasc Pharmacol       Date:  2021-06-01       Impact factor: 3.271

Review 8.  Vascular contributions to cognitive impairment and dementia: the emerging role of 20-HETE.

Authors:  Ezekiel Gonzalez-Fernandez; Yedan Liu; Alexander P Auchus; Fan Fan; Richard J Roman
Journal:  Clin Sci (Lond)       Date:  2021-08-13       Impact factor: 6.876

9.  20-HETE Enzymes and Receptors in the Neurovascular Unit: Implications in Cerebrovascular Disease.

Authors:  Ezekiel Gonzalez-Fernandez; Daniel Staursky; Kathryn Lucas; Bond V Nguyen; Man Li; Yedan Liu; Chad Washington; Lique M Coolen; Fan Fan; Richard J Roman
Journal:  Front Neurol       Date:  2020-09-04       Impact factor: 4.003

10.  20-HETE interferes with insulin signaling and contributes to obesity-driven insulin resistance.

Authors:  Ankit Gilani; Kevin Agostinucci; Sakib Hossain; Jonathan V Pascale; Victor Garcia; Adeniyi Michael Adebesin; John R Falck; Michal Laniado Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2020-10-01       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.